openPR Logo
Press release

Brain Disease Market | Medtronic, Inc., AstraZeneca plc, F. Hoffmann-La Roche Ltd., Boston Scientific Corporation, Sapiens Neuro, and Omeros Corporation

03-29-2019 07:13 AM CET | Health & Medicine

Press release from: TMR Research

Brain Disease Market | Medtronic, Inc., AstraZeneca plc, F. Hoffmann-La Roche Ltd., Boston Scientific Corporation, Sapiens Neuro, and Omeros Corporation

One of the important factors crucial for the growth of the global brain disease market is technological advancement. Recently, scientists at the University of Utah Health and Stanford University have found a way out in the form of a targeted therapy treatment that slows down the progression of or improves a couple of degenerative brain disorders, viz. ataxia and Lou Gehrig’s disease, which is another name for amyotrophic lateral sclerosis (ALS).

WHO has already estimated a billion people to seek treatment for neurological disorders globally, yet there are fewer treatments available today. While the need for brain disease treatment is urgent, highly targeted and noninvasive treatments such as focused ultrasound approved by the Food and Drug Administration (FDA) could attract attention. With the advent of rare brain disease called ‘rat lungworm disease’ in the Hawaii state of the U.S., the need for accurate and responsive treatments is expected to increase significantly.

Get Brochure of the Report @ www.tmrresearch.com/sample/sample?flag=B&rep_id=66

While some scientists argue that humans need less sleep with the progression of age, such changes in sleep hours could aggravate the disintegration associated with brain disorders such as Alzheimer’s disease. Moreover, people above 30 years of age suffering from broken sleep and difficulty sleeping are exposed to a greater risk of brain disease. As a result, with a growing number of population aging above 30 years and rising risks of brain disorders, the growth in the global brain disease market could gain a strong impetus. Other factors that could contribute toward the growth of the global brain disease market include the demand for brain monitoring devices and growing occurrence of neurological disorders.

Global Brain Disease Market: Overview

Any damage caused to the brain through injury or health conditions – commonly known as brain disease – can come in different forms, such as infections, trauma, tumors, seizures, and strokes. Headaches, migraines, poor muscle control, memory problems, vision problems, and vomiting or nausea are some of the common symptoms of brain diseases.

Treatments which are available for various brain diseases depend on the diagnosis. The common treatments include drug medication, surgery, radiation therapy, and chemotherapy.

Global Brain Disease Market: Key Segments and Analyses

Based on the type of infections, the brain disease market can be into meningitis and encephalitis. Meningitis is characterized by an inflammation in the delicate membrane (meninges) that surrounds the brain and the spinal cord. It is commonly caused by bacterial and viral infection. Encephalitis is characterized by an inflammation in the brain tissue. Meningitis and encephalitis commonly occur together and are collectively termed as meningoencephalitis.

Based on the type of trauma, the brain disease market can be segmented into concussion, traumatic brain injury, and hemorrhage. Concussions are highly traumatic brain injuries that affect brain function and result in loss of consciousness and headaches. A traumatic brain injury can lead to permanent brain damage with mental impairment and can also cause changes in the affected individual’s personality. Bleeding in the brain caused by an injury or high blood pressure is referred to as hemorrhage.

Based on the type of tumor, the brain disease market can be segmented into brain tumor, hydrocephalus, and glioblastoma. Hydrocephalus is a condition in which there is an increase in the amount of cerebrospinal fluid inside the skull, while a glioblastoma is a brain tumor that is highly cancerous and usually occurs in the cerebrum of adults.

Global Brain Disease Market: Geographical Analysis

Based on geography, the global brain disease market can be segmented into North America, Europe, Asia Pacific and the rest of the world. For 2016, North America held the leading position in the market, followed by Europe. The key drivers for the two regions include a consistently increasing prevalence of neurological diseases and a rising demand for technologically advanced medical equipments for treatment. According to the Central Brain Tumor Registry of the United States, around 350,000 brain and nervous system tumor cases have been registered in the U.S. European countries are also expected to show a steady growth rate in the global brain disease market. In the next few years, Asia Pacific is likely to show a remarkable growth in the brain disease market through fast-paced developments in healthcare infrastructure and a growing demand for advanced treatments. Other factors which could fuel the growth of the market in Asia Pacific are a growing awareness regarding various brain disorders and an increase in the number of patients getting affected with neurological disorders.

Get TOC for Detailed Facts and Numbers @ www.tmrresearch.com/sample/sample?flag=T&rep_id=66

Global Brain Disease Market: Players Mentioned in the Report

It is expected that with time, there will be an influx of more well-established players in the global brain disease market. Some of the leading players operating in the brain disease therapeutics market for 2016 were Medtronic, Inc., AstraZeneca plc, F. Hoffmann-La Roche Ltd., Boston Scientific Corporation, Sapiens Neuro, and Omeros Corporation.

Highlights of the report:

A detailed analysis of key segments of the market
Recent developments in the market’s competitive landscape
Detailed analysis of market segments up to second or third level of segmentation
Historical, current, and projected future valuation of the market in terms of revenue and/or volume
Key business strategies adopted by influential market vendors
Outline of the regulatory framework surrounding and governing numerous aspects of the market
Growth opportunities in emerging and established markets
Recommendations to market players to stay ahead of the competition

About Us:
TMR Research is a premier provider of customized market research and consulting services to business entities keen on succeeding in today’s supercharged economic climate. Armed with an experienced, dedicated, and dynamic team of analysts, we are redefining the way our clients’ conduct business by providing them with authoritative and trusted research studies in tune with the latest methodologies and market trends.

Contact Us:
Rohit Bhisey
Head Internet Marketing
Tel: +1-415-520-1050

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Brain Disease Market | Medtronic, Inc., AstraZeneca plc, F. Hoffmann-La Roche Ltd., Boston Scientific Corporation, Sapiens Neuro, and Omeros Corporation here

News-ID: 1678201 • Views: 769

More Releases from TMR Research

Airport Information Systems Market 2017-2025 | SITA, Rockwell Collins Inc., Siem …
Global Airport Information Systems Market: Snapshot In the past, due to failed traditional screening systems, air operations and passenger safety have been threatened. In order to avoid such mishaps and security breaches, many prominent airports worldwide have heavily invested in real-time monitoring for the efficient examination of operations and detection of possible threats. Get Sample Copy of the Report @ https://www.tmrresearch.com/sample/sample?flag=B&rep_id=30 Airport information systems comprise departure control systems (DCS) and airport operation
Application Delivery Network (ADN) Market Study by 2025 | Brocade, Hewlett-Packa …
Global Application Delivery Network (ADN) Market: Snapshot Cyber-based threats are now being recognized as a top economic risk. Companies are looking at reducing security risks as network complexity is growing multifold. Hence, application delivery network (ADN) aids in safeguarding information from malicious applications and content, while delivering secure, fast, and available applications across enterprises and regulating rising network management costs. Get Sample Copy of the Report @ https://www.tmrresearch.com/sample/sample?flag=B&rep_id=35 Enterprises are
Emergency Management and Incident Management Market 2017-2025 | Booz Allen Hamil …
Global Emergency Management and Incident Management Market: Snapshot The global emergency management and incident management market is expected to see the increased integration of machine-to-machine (M2M) communication technologies and sensors in new-age devices. The capability of new-generation sensing technologies to provide real-time analysis and management of risks related to natural and premeditated risks is expected to compel government bodies to replace ageing and obsolete technologies with the ones with smart sensing
C4ISR Market Study by 2025 | Northrop Grumman, Bae Systems
Global C4ISR Market: Snapshot The global C4ISR market has been displaying immense growth potential over the past few years, thanks to the integration of C41SR systems in the existing platforms, including as land-based, naval, space, and airborne platforms. As the deployment of these systems ensures faster operations at reduced costs, a robust increase in their uptake has been observed across all the platforms. Several technological advancements in the global C4ISR market,

All 26162 Releases


More Releases for Brain

4th International conference on Brain Disorders and Brain Injury
Dear Members, I hope you are doing well This is Karlin Zoe; we would like to invite at our upcoming 4th International Conference on Brain Disorder and Brain Injury on August 14-16, 2017 at Toronto, Canada Participate at this conference and earn up to 20 AMA PRA Category 1 Credits TM Mark your calendar as busy on August 14-16, 2017; they are the official dates for the Brain Injury 2017. Participation benefits: Claim CME
Brain Computer Interface Devices Helps in Curing Brain-Related Disorders
The increasing technological adoption of wearable medical devices is expected to positively support the market for brain computer interface (BCI) technology. The demand for BCI devices is expected to increase primarily in the health care and gaming and entertainment industries. Ageing induces brain-related disorders such as stroke, depression, and Parkinson’s disease. These disorders can be treated with the use of BCI devices. Therefore, the ageing population is one of the
Educating The Female Brain
The growth of the female brain starts it on its unique growth pattern almost from conception which results in significant differences in what females need in schools and their lives as they grow up to educate the female brain. "Almost from conception, the female brain is bathed in estrogen which produces different needs in a female as opposed to the impact of the testosterone bath experienced by males," explained Elizabeth Guarnaccia,
The Aging Brain
Aging begins the moment we are born, as internal and external factors work together to rapidly shape our human experience. Which physiological and psychological factors contribute to cognitive development in youth, and which contribute to degradation as we age? Where do biological and cultural components meet and overlap to shape our cognition, and how does aging affect brain development and memory? Can we actively impact our own brain plasticity? At this
Now Available – Brain Supreme
Brain Supreme is a great new product that is used to handle proper brain health. This product is used to help with ensuring that the brain is able to work with the right possible nutrition. Getting this product to work will be very easy for anyone to handle. Brain Supreme is a product that works as a brain function enhancer. It uses a series of different ingredients for brain functions.
ReelTime Gets Brain Damage
(Cannes, France - October 15, 2007)– ReelTime.com (PINKSHEETS: RLTR)– the video-on-demand broadband network, announced at MIPCOM that they have concluded an agreement with Maxim Media International to license forty films from Maxim’s Brain Damage Films of horror and gore films according to Beverly Zaslow, president and COO of ReelTime. ReelTime will add an additional ten films a month to its library during the term of the agreement. ReelTime.com offers high